Lyrica (pregabalin) NDC 58151-244

NDC codes

FDA NDC Directory

Product NDC (as listed)58151-244Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58151-0244Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58151-244-35	58151024435	473 mL in 1 BOTTLE (58151-244-35)Marketed from Oct 22, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lyrica
Generic name (nonproprietary): pregabalin
Active ingredients: Pregabalin — 20 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Viatris Specialty LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022488
Marketing start: Oct 22, 2024
Listing expires: Dec 31, 2026
DEA schedule: CV
Identifiers: Product ID 58151-244_1c2af07d-faf4-4fc7-b724-c5166746956dSPL ID 1c2af07d-faf4-4fc7-b724-c5166746956dSPL set ID d4734e7d-5079-455e-8ff5-8f4539c998a9RxCUI 483438, 483440, 483442, 483444, 483446, 483448, 483450, 577127, 607018, 607020, 607022, 607024, 607026, 607028, 607033, 607038, 898715, 898718UNII 55JG375S6MUPC 0358151240777, 0358151236770, 0358151239771, 0358151241774, 0358151238774, 0358151242771

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458151024435 followed by a unit qualifier and the quantity

Package 58151-0244-35. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2025.

Indications (excerpt from the label)

LYRICA is indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial‑onset seizures in patients 1 month of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury LYRICA is indicated for: • Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) • Postherpetic neuralgia (PHN) ( 1 ) • Adjunctive therapy for the treatment of partial‑onset seizures in patients 1 month of age and older ( 1 ) • Fibromyalgia ( 1 ) • Neuropathic pain associated with spinal cord injury ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 022488

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022488
Product	Strength	Form · route	Labeler	Product NDC
Pregabalin	Pregabalin 20 mg/mL	SolutionOral	Mylan Pharmaceuticals Inc.	59762-1576